Find us on:News & Press Releases
We recognize that more than a facility is necessary for an attractive successful contract manufacturing organization. Experience operating personnel and management are keys to success. We believe Gallus with have both, benefiting from Mark Bamforth's experienced leadership and the history of successful operation at the St. Louis facility.
Upcoming Events
May 14-15, 2013 - Progressive Clinical Manufacturing Outsourcing - Hamburg, Germany
May 21-23, 2013 - 2. May 21 – 23, 2013 –BIOPHORUM - Cambridge, Massachusetts
June 3-5, 2013 - IBC Single-Use Applications for Biopharmaceutical Manufacturing
News
April 22, 2013 - Gallus BioPharmaceuticals Presents Real World Data From Its "Factory of the Future"
February 26, 2013 - Gallus BioPharmaceuticals Announces Addition of Senior Industry Leader to Its Board of Directors
January 22, 2013 - Gallus announces a new collaboration with Refine Technologies to optimize continuous cell culture processes.
October 24, 2012 - Mediomics LLC Receives Phase II SBIR Contract: Awarded $997,251 to Develop New In-Process Analyzer for Biologics
September 18, 2012 - Gallus BioPharmaceuticals and Roslin Cells Announce an Exclusive Partnership to Supply Cell Therapies for Clients
August 14, 2012 - Gallus BioPharmaceuticals Announces Collaboration Agreement with Natrix Separations Inc.
May 24, 2012 - Gallus BioPharmaceuticals Completes Initial $20 Million Expansion of Early-Phase Clinical Manufacturing Facility
May 15, 2012 - Gallus BioPharmaceuticals's Virtual Ownership Model Thrives with SAP Business All in One
December 6, 2012 - Gallus BioPharmaceuticals Recognized at Greater St. Louis Top 50 Award as Site Continues Expansion
May 24, 2011 - Xcellerex and Gallus BioPharmaceuticals Announce Biomanufacturing Collaboration
May 18, 2011 - Ridgemont Equity Partners To Acquire Majority Interest in Gallus BioPharmaceuticals